38.94
Hinge Health Inc Aktie (HNGE) Neueste Nachrichten
Hinge Health (HNGE) Q4 2025 Earnings Transcript - AOL.com
Hinge Health (HNGE) Climbs 17% on Revenue Jump, Double-Digit Growth Hopes - Bitget
Hinge Health Stock (+17%): Earnings Beat & AI Narrative Ignite Rally - Trefis
10 Stocks Turning Heads With Double-Digit Returns - Insider Monkey
Hinge Health (HNGE) Revenue Growth And Q4 Profit Test Bullish Earnings Narratives - Sahm
Needham reiterates Buy rating on Hinge Health stock, citing strong FY25 finish By Investing.com - Investing.com South Africa
Hinge Health stock price target lowered to $50 by RBC Capital By Investing.com - Investing.com Canada
HNGE Receives Reiteration of Market Outperform Rating by Citizen - GuruFocus
Barclays lowers Hinge Health stock price target to $52 from $60 By Investing.com - Investing.com Canada
Citizens reiterates Market Outperform rating on Hinge Health stock By Investing.com - Investing.com Canada
Why Hinge Health Stock Is Dropping Despite a Beat - TipRanks
Hinge Health Growth Story Weighs AI Scale Against Valuation Upside - Yahoo Finance
Hinge Health (NYSE:HNGE) Digital Care Updates on NYSE Composite - Kalkine Media
Hinge Health (NYSE:HNGE) Shares Gap UpHere's What Happened - MarketBeat
Why Hinge Health Stock Popped on Wednesday - Yahoo Finance
Truist Securities reiterates Buy rating on Hinge Health stock with $63 target By Investing.com - Investing.com South Africa
Hinge Health (NYSE:HNGE) Earns Market Outperform Rating from Citizens Jmp - MarketBeat
Hinge Health stock price target lowered to $50 by RBC Capital - Investing.com Nigeria
Why Hinge Health Stock Popped on Wednesday - The Motley Fool
Truist Securities reiterates Buy rating on Hinge Health stock with $63 target - Investing.com
Hinge Health (NYSE:HNGE) Price Target Cut to $52.00 by Analysts at Barclays - MarketBeat
Barclays lowers Hinge Health stock price target to $52 from $60 - Investing.com India
RBC Cuts Price Target on Hinge Health to $50 From $60, Keeps Outperform Rating - marketscreener.com
Citizens reiterates Market Outperform rating on Hinge Health stock - Investing.com
Needham reiterates Buy rating on Hinge Health stock, citing strong FY25 finish - Investing.com Nigeria
Needham & Company LLC Reiterates "Buy" Rating for Hinge Health (NYSE:HNGE) - MarketBeat
Hinge Health Inc (HNGE) PT Lowered to $50 at RBC Capital - StreetInsider
HNGE: Today's Analyst Ratings and Price Target Update | HNGE Sto - GuruFocus
Why Is Hinge Health Stock Soaring Wednesday? - Benzinga
Breaking Down Hinge Health: 7 Analysts Share Their Views - Benzinga
How AI investments are driving Hinge Health’s growth - Modern Healthcare News
Hinge Health outlines 25% revenue growth target for 2026 while expanding AI-driven care - MSN
Hinge Health Q4 Adjusted Earnings, Revenue Rise; Shares Jump Pre-Bell - marketscreener.com
Hinge Health Q4 Earnings Call Highlights - MarketBeat
Hinge Health Q4 2025 Earnings Call Transcript - MarketBeat
Hinge Health Reports Strong Q4 2025 Earnings with 46% Revenue Growth - Intellectia AI
Hinge Health Q4 2025 slides: 46% revenue growth, margins expand amid AI push - Investing.com Nigeria
Hinge Health reports fourth quarter and full year 2025 financial results - The National Law Review
Hinge Health reports Q4 EPS 49c, consensus 43c - TipRanks
Earnings call transcript: Hinge Health Q4 2025 delivers strong earnings beat By Investing.com - Investing.com South Africa
HINGE HEALTH INC-A (NYSE:HNGE) Crushes Q4 Estimates and Provides Strong 2026 Guidance - ChartMill
Earnings call transcript: Hinge Health Q4 2025 delivers strong earnings beat - Investing.com
Hinge Health (NYSE:HNGE) Posts Quarterly Earnings Results - MarketBeat
Hinge Health sees Q1 revenue $171M-$173M, consensus $159.67M - TipRanks
Hinge Health Q4 Adjusted Earnings, Revenue Rise; Shares Up After Hours - marketscreener.com
Why Hinge Health, Inc. Class A Shares Are Sinking - TipRanks
Hinge Health soars as Q4 earnings triple estimates, outlook tops consensus - Investing.com India
(HNGE) Hinge Health Expects Full Year 2026 Revenue Range $732M$742M, vs. FactSet Est of $702.9M - marketscreener.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):